Core B: Neuroimaging Core
核心 B:神经影像核心
基本信息
- 批准号:10684077
- 负责人:
- 金额:$ 27.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary – Neuroimaging Core – Core B
The Neuroimaging Core will provide UC Davis CounterACT Center investigators with outstanding resources in
the rapidly evolving field of neuroimaging technologies, for which there is strong demand by all three scientific
Projects. Neuroimaging tools provide one of the best modern means for examining the pathophysiology of
disorders that affect the brain. Center investigators have previously shown the benefits of neuroimaging
technologies for evaluating the short- and long-term consequences of acute organophosphate intoxication on
the brain and identifying effective therapeutic strategies that mitigate the resulting neuropathology. The
Neuroimaging Core will capitalize on these previous successes and provide state-of-the-art equipment for
neuroimaging spanning microscopic to whole brain in vivo imaging, and dedicated expertise in image acquisition,
analysis and the development and validation of imaging biomarkers to support the scientific Projects. The
neuroimaging resources provided will include modalities focused on structural neuroimaging, such as magnetic
resonance imaging (MRI) and X-ray computed tomography (CT), functional and molecular imaging, such as MRI
and positron emission tomography (PET), and correlative cellular high-content brightfield and fluorescence tissue
imaging. Oversight and management of the Neuroimaging Core will be provided by Core Lead, Abhijit Chaudhari,
PhD, Professor of Radiology and the Director of the UC Davis Center for Molecular and Genomic Imaging
(CMGI), with over 15 years of experience in animal and human imaging with various imaging modalities,
quantitative imaging science, imaging biomarker design and validation and medical image processing; and Core
Co-Lead, Brad Hobson, PhD, Research Scientist at the CMGI, who has extensive training in neurotoxicology,
pharmacology and the validation of ex vivo and in vivo neuroimaging methods in the context of organophosphate
exposure. The objectives of the Neuroimaging Core are to: (1) provide Center investigators with access to a
wide array of neuroimaging technologies ranging from cellular imaging to macroscopic in vivo structural,
functional, and molecular imaging in pursuit of the scientific aims of the Projects; (2) develop and deploy
advanced imaging technologies that will enhance Center investigators’ research endeavors.; and (3) contribute
to the research education mission of the Center by providing virtual and hands-on training in the utilization of
imaging methods, data acquisition, and image analysis. By providing neuroimaging expertise, the Core will
ensure that imaging studies by the UC Davis Center investigators are designed, implemented, and analyzed
rigorously to ensure transparency, reproducibility and future translatability to humans.
项目摘要 - 神经成像核心 - 核心B
神经影像核心将为UC Davis Rultact Center调查人员提供出色的资源
神经影像技术的快速发展的领域,这三种科学的需求强劲
项目。神经影像学工具提供了研究的最佳现代手段之一
影响大脑的疾病。中心调查人员以前已经显示了神经影像的好处
评估急性有机磷酸盐中毒对短期和长期后果的技术
大脑并确定减轻由此产生的神经病理学的有效治疗策略。
神经影像学核心将利用这些先前的成功,并为
神经影像跨越体内大脑的微观成像,并在图像采集方面专门专业知识,
分析以及成像生物标志物的开发和验证以支持科学项目。这
提供的神经影像资源将包括关注结构神经影像学的方式,例如磁性
共振成像(MRI)和X射线计算机断层扫描(CT),功能和分子成像,例如MRI
和正电子发射断层扫描(PET),以及校正细胞高含量的明亮场和荧光组织
成像。核心负责人Abhijit Chaudhari将提供对神经影像核心的监督和管理
PhD,放射学教授,加州大学戴维斯分子和基因组成像中心主任
(CMGI),具有多种成像方式的动物和人类成像经验超过15年,
定量成像科学,成像生物标志物设计,验证以及医学图像处理;和核心
CMGI的CORAD HOBSON,BRAD HOBSON,博士学位,他在神经毒理学方面接受了广泛的培训,
在有机磷酸盐的情况下,药理学和体内和体内神经影像学方法的验证
接触。神经成像核心的对象是:(1)为中心调查人员提供访问
从细胞成像到体内结构的宏观成像,各种各样的神经影像学技术,
功能和分子成像,以追求项目的科学目的; (2)开发和部署
高级成像技术将增强中心研究人员的研究努力。 (3)贡献
通过在利用中提供虚拟和动手培训来实现中心的研究教育任务
成像方法,数据采集和图像分析。通过提供神经影像学专业知识,核心将
确保设计,实施和分析加州大学戴维斯分校中心研究人员的成像研究
严格地确保对人类的透明度,可重复性和未来的翻译性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Abhijit J Chaudhar...的其他基金
Multimodality PET/CT Scanner for Small Animal Imaging
用于小动物成像的多模态 PET/CT 扫描仪
- 批准号:1042945810429458
- 财政年份:2022
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Total-body PET for assessing myofascial pain
用于评估肌筋膜疼痛的全身 PET
- 批准号:1057150810571508
- 财政年份:2022
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Imaging biomarkers of early synaptic changes in a preclinical model of Alzheimer’s disease
阿尔茨海默病临床前模型中早期突触变化的成像生物标志物
- 批准号:99807569980756
- 财政年份:2019
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Total-Body PET/CT for assessing Rheumatoid Arthritis Disease Activity and Treatment Response
全身 PET/CT 用于评估类风湿性关节炎疾病活动性和治疗反应
- 批准号:98171059817105
- 财政年份:2019
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Quantifying synaptic density loss in a monkey model of early Alzheimer's Disease
量化早期阿尔茨海默病猴子模型中的突触密度损失
- 批准号:98092809809280
- 财政年份:2019
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Total-Body PET/CT for assessing Rheumatoid Arthritis Disease Activity and Treatment Response
全身 PET/CT 用于评估类风湿性关节炎疾病活动性和治疗反应
- 批准号:1022085210220852
- 财政年份:2019
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Imaging biomarkers of early synaptic changes in a preclinical model of Alzheimer’s disease
阿尔茨海默病临床前模型中早期突触变化的成像生物标志物
- 批准号:98079999807999
- 财政年份:2019
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Quasi-rigid image registration for DCE-MRI
DCE-MRI 的准刚性图像配准
- 批准号:85988738598873
- 财政年份:2013
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Quasi-rigid image registration for DCE-MRI
DCE-MRI 的准刚性图像配准
- 批准号:84451828445182
- 财政年份:2013
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
In Vivo Translational Imaging Shared Resource
体内转化成像共享资源
- 批准号:1049261510492615
- 财政年份:2002
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
相似国自然基金
急性眼内压升高对猕猴视觉皮层功能影响的研究
- 批准号:81900852
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
呼气末正压对不同呼吸力学属性猪颅高压模型的颅内压和脑代谢的影响
- 批准号:81701942
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
急性低氧影响大鼠脑血流动力学的机制研究
- 批准号:81560301
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
人脐血干细胞移植对兔急性脑梗死脑磁共振波谱的影响及其安全性研究
- 批准号:81171108
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
SURF1基因新突变对COX功能的影响及致病机制探讨
- 批准号:30471832
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:1066033210660332
- 财政年份:2023
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Protein tyrosine phosphatase non-receptor 14 in vascular stability and remodeling
蛋白酪氨酸磷酸酶非受体 14 在血管稳定性和重塑中的作用
- 批准号:1066050710660507
- 财政年份:2023
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Biophysical Mechanisms of Cortical MicroStimulation
皮质微刺激的生物物理机制
- 批准号:1071172310711723
- 财政年份:2023
- 资助金额:$ 27.2万$ 27.2万
- 项目类别:
Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures
用于治疗和预防耐药性癫痫发作的研究性 WNT 通路调节剂
- 批准号:1072545010725450
- 财政年份:2023
- 资助金额:$ 27.2万$ 27.2万
- 项目类别: